Park Avenue Securities’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.27M | Buy |
89,674
+694
| +0.8% | +$48.5K | 0.06% | 241 |
|
|
2025
Q1 | $6.54M | Buy |
88,980
+11,668
| +15% | +$858K | 0.08% | 171 |
|
|
2024
Q4 | $5.07M | Buy |
77,312
+14,711
| +23% | +$964K | 0.05% | 241 |
|
|
2024
Q3 | $4.88M | Sell |
62,601
-6,789
| -10% | -$529K | 0.05% | 221 |
|
|
2024
Q2 | $5.41M | Buy |
69,390
+16,161
| +30% | +$1.26M | 0.07% | 201 |
|
|
2024
Q1 | $3.61M | Buy |
53,229
+565
| +1% | +$38.3K | 0.05% | 255 |
|
|
2023
Q4 | $3.55M | Buy |
52,664
+7,626
| +17% | +$514K | 0.05% | 229 |
|
|
2023
Q3 | $3.05M | Buy |
45,038
+4,782
| +12% | +$324K | 0.05% | 238 |
|
|
2023
Q2 | $2.88M | Buy |
40,256
+25
| +0.1% | +$1.79K | 0.05% | 240 |
|
|
2023
Q1 | $2.79M | Buy |
40,231
+8,832
| +28% | +$613K | 0.05% | 227 |
|
|
2022
Q4 | $2.13M | Buy |
31,399
+2,566
| +9% | +$174K | 0.04% | 296 |
|
|
2022
Q3 | $1.58M | Buy |
28,833
+6,604
| +30% | +$362K | 0.03% | 315 |
|
|
2022
Q2 | $1.47M | Buy |
22,229
+3,321
| +18% | +$219K | 0.03% | 339 |
|
|
2022
Q1 | $1.25M | Buy |
18,908
+1,339
| +8% | +$88.8K | 0.02% | 402 |
|
|
2021
Q4 | $1.02M | Sell |
17,569
-1,283
| -7% | -$74.7K | 0.02% | 466 |
|
|
2021
Q3 | $1.13M | Buy |
18,852
+7,139
| +61% | +$429K | 0.02% | 373 |
|
|
2021
Q2 | $702K | Buy |
11,713
+2,752
| +31% | +$165K | 0.01% | 518 |
|
|
2021
Q1 | $446K | Buy |
8,961
+1,819
| +25% | +$90.5K | 0.01% | 623 |
|
|
2020
Q4 | $357K | Buy |
7,142
+2,864
| +67% | +$143K | 0.01% | 612 |
|
|
2020
Q3 | $234K | Sell |
4,278
-501
| -10% | -$27.4K | 0.01% | 664 |
|
|
2020
Q2 | $253K | Buy |
+4,779
| New | +$253K | 0.01% | 565 |
|